TY - JOUR
T1 - Copy Number Variant Analysis and Genome-wide Association Study Identify Loci with Large Effect for Vesicoureteral Reflux
AU - Verbitsky, Miguel
AU - Krithivasan, Priya
AU - Batourina, Ekaterina
AU - Khan, Atlas
AU - Graham, Sarah E
AU - Marasà, Maddalena
AU - Kim, Hyunwoo
AU - Lim, Tze Y
AU - Weng, Patricia L
AU - Sánchez-Rodríguez, Elena
AU - Mitrotti, Adele
AU - Ahram, Dina F
AU - Zanoni, Francesca
AU - Fasel, David A
AU - Westland, Rik
AU - Sampson, Matthew G
AU - Zhang, Jun Y
AU - Bodria, Monica
AU - Kil, Byum Hee
AU - Shril, Shirlee
AU - Gesualdo, Loreto
AU - Torri, Fabio
AU - Scolari, Francesco
AU - Izzi, Claudia
AU - van Wijk, Joanna A E
AU - Saraga, Marijan
AU - Santoro, Domenico
AU - Conti, Giovanni
AU - Barton, David E
AU - Dobson, Mark G
AU - Puri, Prem
AU - Furth, Susan L
AU - Warady, Bradley A
AU - Pisani, Isabella
AU - Fiaccadori, Enrico
AU - Allegri, Landino
AU - Degl'Innocenti, Maria Ludovica
AU - Piaggio, Giorgio
AU - Alam, Shumyle
AU - Gigante, Maddalena
AU - Zaza, Gianluigi
AU - Esposito, Pasquale
AU - Lin, Fangming
AU - Simões-E-Silva, Ana Cristina
AU - Brodkiewicz, Andrzej
AU - Drozdz, Dorota
AU - Zachwieja, Katarzyna
AU - Miklaszewska, Monika
AU - Szczepanska, Maria
AU - Adamczyk, Piotr
AU - Tkaczyk, Marcin
AU - Tomczyk, Daria
AU - Sikora, Przemyslaw
AU - Mizerska-Wasiak, Malgorzata
AU - Krzemien, Grazyna
AU - Szmigielska, Agnieszka
AU - Zaniew, Marcin
AU - Lozanovski, Vladimir J
AU - Gucev, Zoran
AU - Ionita-Laza, Iuliana
AU - Stanaway, Ian B
AU - Crosslin, David R
AU - Wong, Craig S
AU - Hildebrandt, Friedhelm
AU - Barasch, Jonathan
AU - Kenny, Eimear E
AU - Loos, Ruth J F
AU - Levy, Brynn
AU - Ghiggeri, Gian Marco
AU - Hakonarson, Hakon
AU - Latos-Bieleńska, Anna
AU - Materna-Kiryluk, Anna
AU - Darlow, John M
AU - Tasic, Velibor
AU - Willer, Cristen
AU - Kiryluk, Krzysztof
AU - Sanna-Cherchi, Simone
AU - Mendelsohn, Cathy L
AU - Gharavi, Ali G
AU - Verbitsky M
N1 - Copyright © 2021 by the American Society of Nephrology.
PY - 2021/2/17
Y1 - 2021/2/17
N2 - BACKGROUND: Vesicoureteral reflux (VUR) is a common, familial genitourinary disorder, and a major cause of pediatric urinary tract infection (UTI) and kidney failure. The genetic basis of VUR is not well understood.METHODS: A diagnostic analysis sought rare, pathogenic copy number variant (CNV) disorders among 1737 patients with VUR. A GWAS was performed in 1395 patients and 5366 controls, of European ancestry.RESULTS: Altogether, 3% of VUR patients harbored an undiagnosed rare CNV disorder, such as the 1q21.1, 16p11.2, 22q11.21, and triple X syndromes ((OR, 3.12; 95% CI, 2.10 to 4.54; P=6.35×10-8) The GWAS identified three study-wide significant and five suggestive loci with large effects (ORs, 1.41-6.9), containing canonical developmental genes expressed in the developing urinary tract (WDPCP, OTX1, BMP5, VANGL1, and WNT5A). In particular, 3.3% of VUR patients were homozygous for an intronic variant in WDPCP (rs13013890; OR, 3.65; 95% CI, 2.39 to 5.56; P=1.86×10-9). This locus was associated with multiple genitourinary phenotypes in the UK Biobank and eMERGE studies. Analysis of Wnt5a mutant mice confirmed the role of Wnt5a signaling in bladder and ureteric morphogenesis.CONCLUSIONS: These data demonstrate the genetic heterogeneity of VUR. Altogether, 6% of patients with VUR harbored a rare CNV or a common variant genotype conferring an OR >3. Identification of these genetic risk factors has multiple implications for clinical care and for analysis of outcomes in VUR.
AB - BACKGROUND: Vesicoureteral reflux (VUR) is a common, familial genitourinary disorder, and a major cause of pediatric urinary tract infection (UTI) and kidney failure. The genetic basis of VUR is not well understood.METHODS: A diagnostic analysis sought rare, pathogenic copy number variant (CNV) disorders among 1737 patients with VUR. A GWAS was performed in 1395 patients and 5366 controls, of European ancestry.RESULTS: Altogether, 3% of VUR patients harbored an undiagnosed rare CNV disorder, such as the 1q21.1, 16p11.2, 22q11.21, and triple X syndromes ((OR, 3.12; 95% CI, 2.10 to 4.54; P=6.35×10-8) The GWAS identified three study-wide significant and five suggestive loci with large effects (ORs, 1.41-6.9), containing canonical developmental genes expressed in the developing urinary tract (WDPCP, OTX1, BMP5, VANGL1, and WNT5A). In particular, 3.3% of VUR patients were homozygous for an intronic variant in WDPCP (rs13013890; OR, 3.65; 95% CI, 2.39 to 5.56; P=1.86×10-9). This locus was associated with multiple genitourinary phenotypes in the UK Biobank and eMERGE studies. Analysis of Wnt5a mutant mice confirmed the role of Wnt5a signaling in bladder and ureteric morphogenesis.CONCLUSIONS: These data demonstrate the genetic heterogeneity of VUR. Altogether, 6% of patients with VUR harbored a rare CNV or a common variant genotype conferring an OR >3. Identification of these genetic risk factors has multiple implications for clinical care and for analysis of outcomes in VUR.
U2 - 10.1681/ASN.2020050681
DO - 10.1681/ASN.2020050681
M3 - Article
C2 - 33597122
SN - 1046-6673
JO - Journal of the American Society of Nephrology
JF - Journal of the American Society of Nephrology
ER -